Several ESCC tumor microenvironment studies, predominantly targeting the immune checkpoint PD-1, have demonstrated the predictive potential of the content and spatial interrelationships of active immune cells in TIL for the treatment of malignancies [10, 13, 14]. Here, PDCD1 is linked to neoplasm.